Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Grows By 485.4%

Siemens Healthineers AG (OTCMKTS:SMMNY) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 116,151 shares, an increase of 485.4% from the May 31st total of 19,840 shares. Based on an average trading volume of 284,099 shares, the short-interest ratio is currently 0.4 days.

Siemens Healthineers Trading Down 0.5%

Shares of SMMNY traded down $0.09 during midday trading on Friday, hitting $19.44. The company’s stock had a trading volume of 337,069 shares, compared to its average volume of 170,126. Siemens Healthineers has a one year low of $19.32 and a one year high of $28.92. The company’s fifty day simple moving average is $20.23 and its two-hundred day simple moving average is $22.88.

Siemens Healthineers (OTCMKTS:SMMNY) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.02. The business had revenue of $6.68 billion for the quarter, compared to the consensus estimate of $6.96 billion.

Analysts Set New Price Targets

Separately, Zacks Research downgraded Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.